Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This indicates a minor update to the page’s template/metadata without changing the study content or user-facing details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a non-content release update.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study content or page functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check83 days agoChange DetectedResults posting details were added, including dates when results were first posted. The study documents were expanded with links to the protocol and informed consent forms, and the outcome measures were updated to specify RECIST-based endpoints and include multiple drug name synonyms.SummaryDifference5%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.